Genetic relationship between central β-endorphin and novelty-induced locomotor activity

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 709-718

  Radcliffe, Richard A ^a   Erwin, V Gene ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Amygdala; Genetics; Hypothalamus; Inbred mice; Midbrain; Naltrexone; Open field activity; Pituitary; Proopiomelanocortin; Recombinant; Septum; Endorphin

Indexed keywords

BETA ENDORPHIN; NALTREXONE; PROOPIOMELANOCORTIN;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; GENETIC REGULATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HYPOPHYSIS; HYPOTHALAMUS; LOCOMOTION; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STRAIN DIFFERENCE;

EID: 0031874726     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00045-8     Document Type: Article

References (44)

1. Akil, H.; Bronstein, D.; Mansour, A.: Overview of the endogenous opioid systems: Anatomical, biochemical and functional issues. In: Rodgers, R. J.; Cooper, S. J., eds. Endorphins, opiates and behavioural processes. New York: John Wiley & Sons Ltd.; 1988:1-23.
2. Baubet, V.; Fevre-Montange, M.; Gay, N.; Debilly, G.; Bobillier, P.; Cespuglio, R.: Effects of an acute immobilization stress upon proopiomelanocortin (POMC) mRNA levels in the mediobasal hypothalamus: A quantitative in situ hybridization study. Brain Res. Mol. Brain Res. 26:163-168; 1994.
3. Belknap, J. K.; Crabbe, J. C.: Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Ann. NY Acad. Sci. 654:311-323; 1992.
4. Belknap, J. K.; Mogil, J. S.; Helms, M. L.; Richards, S. P.; O'Toole, L. A.; Bergeson, S. E.; Buck, K. J.: Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci. 57:PL117-PL124; 1995.
5. 3H/ HeJ inbred mouse strains. Physiol. Behav. 46:69-74; 1989.
6. Bostock, E.; Gallagher, M.; King, R. A.: Effects of opioid micro-injections into the medial septal area on spatial memory in rats. Behav. Neurosci. 102:643-652; 1988.
7. Calenco-Choukroun, G.; Dauge, V.; Gacel, G.; Feger, J.; Roques, B. P.: Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area. Psychopharmacology (Berlin) 103:493-502; 1991.
8. Castellano, C.: Strain dependent effects of the enkephalin analogue FK 33-824 on locomotor activity in mice. Pharmacol. Biochem. Behav. 15:729-734; 1981.
9. Crabbe, J. C.; Allen, R. G.; Gaudette, N. D.; Young, E. R.; Kosobud, A.; Stack, J.: Strain differences in pituitary β-endorphin and ACTH content in inbred mice. Brain Res. 219:219-223; 1981.
10. Davis, M.: The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15:353-375; 1992.
11. DeFries, J. C.; Wilson, J. R.; Erwin, V. G.; Petersen, D. R.: LSXSS recombinant inbred strains of mice: Initial characterization. Alcohol. Clin. Exp. Res. 13:196-200; 1989.
12. de Wied, D.; Jolles, J.: Neuropeptides derived from pro-opiocortin: Behavioral, physiological, and neurochemical effects. Physiol. Rev. 62:976-1059; 1982.
13. Erwin, V. G.; Radcliffe, R.; Jones, B. C.: Chronic ethanol consumption produces genotype-dependent tolerance to ethanol in LS/lbg and SS/lbg mice. Pharmacol. Biochem. Behav. 41:275-281; 1992.
14. File, S. E.; Rodgers, R. J.: Partial anxiolytic action of morphine sulphate following microinjection into the central nucleus of the amygdala in rats. Pharmacol. Biochem. Behav. 11:313-318; 1979.
15. Gallagher, M.; Chiba, A. A.: The amygdala and emotion. Curr. Opin. Neurobiol. 6:221-227; 1996.
16. Gallagher, M.; Kapp, B. S.: Manipulation of opiate activity in the amygdala alters memory processes. Life Sci. 23:1973-1977; 1978.
17. Gallagher, M.; Kapp, B. S.; Pascoe, J. P.: Enkephalin analogue effects in the amygdala central nucleus on conditioned heart rate. Pharmacol. Biochem. Behav. 17:217-222; 1982.
18. Gallagher, M.; Kapp, B. S.; McNall, C. L.; Pascoe, J. P.: Opiate effects in the amygdala central nucleus on heart rate conditioning in rabbits. Pharmacol. Biochem. Behav. 14:497-505; 1981.
19. Gallagher, M.; Meagher, M. W.; Bostock, E.: Effects of opiate manipulations on latent inhibition in rabbits: Sensitivity of the medial septal region to intracranial treatments. Behav. Neurosci. 101:315-324; 1987.
20. Ibata, Y.; Kawakami, F.; Okamura, H.; Obata-Tsuto, H. L.; Morimoto, N.; Zimmerman, E. A.: Light and electron microscopic immunocytochemistry of β-endorphin/β-LPH-like immunoreactive neurons in the arcuate nucleus and surrounding areas of the rat hypothalamus. Brain Res. 341:233-242; 1985.
21. Izquierdo, I.; Souza, D. O.; Carrasco, M. A.; Dias, R. D.; Perry, M. L.; Eisinger, S.; Elisabetsky, E.; Vendite, D. A.: Beta-endorphin causes retrograde amnesia and is released from the rat brain by various forms of training and stimulation. Psychopharmacology (Berlin) 70:173-177; 1980.
22. Izquierdo, I.; Souza, D. O.; Dias, R. D.; Perry, M. L.; Carrasco, M. A.; Volkmer, N.; Netto, C. A.: Effect of various behavioral training and testing procedures on brain beta-endorphin-like immunoreactivity and the possible role of beta-endorphin in behavioral regulation. Psychoneuroendocrinology 9:381-389; 1984.
23. Kalivas, P. W.; Abhold, R.: Enkephalin release into the ventral tegmental area in response to stress: Modulation of mesocorticolimbic dopamine. Brain Res. 414:339-348; 1987.
24. Kalivas, P. W.; Bronson, M.: Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology 24:931-936; 1985.
25. Katz, R. J.; Carroll, B. J.: Enkephalin-dopamine interactions in behavioral arousal. Prog. Neuropsychopharmacol. 3:395-398; 1979.
26. Katz, R. J.: Opiate stimulation increases exploration in the mouse. Int. J. Neurosci. 9:213-215; 1979.
27. Khawaja, X. Z.; Chattopadhyay, A. K.; Green, I. C.: Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Res. 555:164-168; 1991.
28. Latimer, L. G.; Duffy, P.; Kalivas, P. W.: Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:328-337; 1987.
29. Marek, P.; Mogil, J. S.; Belknap, J. K.; Sadowski, B.; Liebeskind, J. C.: Levorphanol and swim stress-induced analgesia in selectively bred mice: Evidence for genetic commonalities. Brain Res. 608:353-357; 1993.
30. McClearn, G. E.; Kakihana, R.: Selective breeding for ethanol sensitivity in mice. Behav. Gen. 3:409-410; 1973.
31. Mogil, J. S.; Marek, P.; O'Toole, L. A.; Helms, M. L.; Sadowski, B.; Liebeskind, J. C.; Belknap, J. K.: Mu-opiate receptor binding is upregulated in mice selectively bred for high stress-induced analgesia. Brain Res. 653:16-22; 1994.
32. Oliverio, A.; Castellano, C.: Behavioral effects of opiates: A pharmacogenetic analysis. Curr. Dev. Psychopharmacol. 6:45-64; 1981.
33. Pesold, C.; Treit, D.: Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests. Physiol. Behav. 52:37-47; 1992.
34. Puglisi-Allegra, S.; Castellano, C.; Filibeck, U.; Oliverio, A.; Melchiorri, P.: Behavioural data on dermorphins in mice. Eur. J. Pharmacol. 82:223-227; 1982.
35. Radcliffe, R. A.; Jones, B. C.; Erwin, V. G.: Mapping of provisional quantitative trait loci influencing temporal variation in locomotor acvtivity in the LSXSS recombinant inbred strains. Behav. Genet. 28:39-47; 1998.
36. Radcliffe, R. A.; Walter, N. A. R.; Sikela, J. M.; Erwin, V. G.: Discovery of a new Pomc1 allele in the LSXSS recombinant inbred strains: Relationship to locomotor activity. Behav. Genet. 28:49-55; 1998.
37. Ragozzino, M. E.; Gold, P. E.: Glucose injections into the medial septum reverse the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience 68:981-988; 1995.
38. Rubinstein, M.; Mortrud, M.; Liu, B.; Low, M. J.: Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice. Neuroendocrinology 58:373-380; 1993.
39. Segal, D. S.; Browne, R. G.; Arnsten, A.; Derrington, D. C.; Bloom, F. E.; Davis, A. V.; Guillemin, R.; Ling, N.: Characteristics of β-endorphin-induced behavioral activation and immobilization. In: Usdin, E.; Bunney, W. E.; Kline, N. S., eds. Endorphins in mental health research. New York: Oxford University Press; 1979:307-324.
40. Silver, L. M.: Mouse genetics: Concepts and applications. New York: Oxford University Press; 1995.
41. Slotnick, B. M.; Leonard, C. M.: Stereotaxic Atlas of the albino mouse forebrain. DHEW Publication (ADN) 75-100; 1975.
42. Spanagel, R.; Herz, A.; Bals-Kubik, R.; Shippenberg, T. S.: Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berlin) 104:51-56; 1991.
43. Ukai, M.; Kameyama, T.: The antagonistic effects of naloxone on hypermotility in mice induced by dynorphin-(1-13) using a multi-dimensional behavioral analysis. Neuropharmacology 23:165-168; 1984.
44. Ukai, M.; Yamada, S.; Kameyama, T.: Naloxone reserves the inhibitory effects of dynorphin A on motor activity in the mouse. Pharmacol. Biochem. Behav. 20:815-818; 1984.